Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical tria…
Biotechnology
US, Bala Cynwyd [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Larimar Therapeutics, Inc. (LRMR) to it's peer group.
Peer Group
PCVX CABA IKNA ALEC SNDX DAWN CELC SPRO FIXX NLTX KZR STRO SRZN KROS BOLT IMRX CHRS
Compare Together
Loading...